TY - JOUR
T1 - Revisiting fetal dose during radiation therapy
T2 - Evaluating treatment techniques and a custom shield
AU - Owrangi, Amir M.
AU - Roberts, Donald A.
AU - Covington, Elizabeth L.
AU - Hayman, James A.
AU - Masi, Kathryn M.
AU - Lee, Choonik
AU - Moran, Jean M.
AU - Prisciandaroa, Joann I.
N1 - Funding Information:
The authors would like to acknowledge the support of the University of Michigan's Fostering Innovation Grants (FIGs) for funding the design and build of the fetal shield. We would like to thank Michael Deininger and Laura McCormick from the University of Michigan Medical Innovation Center for our multiple discussions on the concept of the fetal shield, and the final design of the shield. We would like to thank Fame Industries Inc. (Wixom, MI) for constructing the frame and drive mechanism for the fetal shield. Lastly, we would like to acknowledge Dr. Kwok Lam for his many lively and fruitful discussions on shield designs and pertinent commissioning measurements.
Publisher Copyright:
© Creative Commons Attribution 3.0 Unported License.
PY - 2016
Y1 - 2016
N2 - To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58% at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.
AB - To create a comprehensive dataset of peripheral dose (PD) measurements from a new generation of linear accelerators with and without the presence of a newly designed fetal shield, PD measurements were performed to evaluate the effects of depth, field size, distance from the field edge, collimator angle, and beam modifiers for common treatment protocols and modalities. A custom fetal lead shield was designed and made for our department that allows external beam treatments from multiple angles while minimizing the need to adjust the shield during patient treatments. PD measurements were acquired for a comprehensive series of static fields on a stack of Solid Water. Additionally, PDs from various clinically relevant treatment scenarios for pregnant patients were measured using an anthropomorphic phantom that was abutted to a stack of Solid Water. As expected, the PD decreased as the distance from the field edge increased and the field size decreased. On average, a PD reduction was observed when a 90° collimator rotation was applied and/or when the tertiary MLCs and jaws defined the field aperture. However, the effect of the collimator rotation (90° versus 0°) in PD reduction was not found to be clinically significant when the tertiary MLCs were used to define the field aperture. In the presence of both the MLCs and the fetal shield, the PD was reduced by 58% at a distance of 10 cm from the field edge. The newly designed fetal shield may effectively reduce fetal dose and is relatively easy to setup. Due to its design, we are able to use a broad range of treatment techniques and beam angles. We believe the acquired comprehensive PD dataset collected with and without the fetal shield will be useful for treatment teams to estimate fetal dose and help guide decisions on treatment techniques without the need to perform pretreatment phantommeasurements.
KW - Fetal shield
KW - Fetus
KW - Out-of-field dose
KW - Peripheral dose
UR - http://www.scopus.com/inward/record.url?scp=84995582000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995582000&partnerID=8YFLogxK
U2 - 10.1120/jacmp.v17i5.6135
DO - 10.1120/jacmp.v17i5.6135
M3 - Article
C2 - 27685109
AN - SCOPUS:84995582000
SN - 1526-9914
VL - 17
SP - 34
EP - 46
JO - Journal of Applied Clinical Medical Physics
JF - Journal of Applied Clinical Medical Physics
IS - 5
ER -